Historical record - last NADAC effective date: 2/22/2023

Product Information

OLMESARTAN MEDOXOMIL 5 MG TAB is a generic product labeled by Lifestar Pharma LLC, priced at $0.0622 per EA under NDC 70756080830. Its NADAC has been published 133 times since Aug 12, 2020.

FDA first approved this application on Jul 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the OLMESARTAN MEDOXOMIL market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OLMESARTAN MEDOXOMIL 5 MG TAB

OLMESARTAN MEDOXOMIL
$0.0622per EA
High Outlier

Strength

5 mg/1

NDC

70756080830

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

2/22/2023

Active Ingredients

OLMESARTAN MEDOXOMIL

Approval Type

Generic (ANDA)

FDA Application

ANDA207135

FDA Approved

7/18/2019

TE Code

AB

On Market Since

5/1/2020

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has been published 133 times since Aug 12, 2020, and over the history we have for it it has declined 28.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0622 per EA
All-time high$0.1085 (Nov 11, 2020)
All-time low$0.0616 (Jan 18, 2023)
Median price$0.0772
Average price$0.0790
Largest weekly change+29.3% (Apr 21, 2021)
Weeks tracked133
Tracking sinceAug 12, 2020

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

-29.7%

All

-28.3%

Last surveyed Feb 22, 2023 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 11%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of OLMESARTAN MEDOXOMIL 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 5 MG TAB, manufactured by Lifestar Pharma LLC, is $0.0622 per EA (NDC 70756080830), effective Feb 22, 2023.

How has the price of OLMESARTAN MEDOXOMIL 5 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has declined 28.3%. It has been tracked across 133 weekly CMS publications since Aug 12, 2020.

What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 5 MG TAB?

Since Aug 12, 2020, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has ranged from a low of $0.0616 (Jan 18, 2023) to a high of $0.1085 (Nov 11, 2020), with a median of $0.0772 per EA.

Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 5 MG TAB?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 5 MG TAB, is $0.0551 per EA — about 11% below OLMESARTAN MEDOXOMIL 5 MG TAB.

Who manufactures OLMESARTAN MEDOXOMIL 5 MG TAB?

OLMESARTAN MEDOXOMIL 5 MG TAB (NDC 70756080830) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.